MA26590A1 - Derives de thiazole, leur procede de preparation et leur utilisation. - Google Patents

Derives de thiazole, leur procede de preparation et leur utilisation.

Info

Publication number: MA26590A1
Authority: MA; Morocco
Prior art keywords: preparation process; thiazole derivatives; thiazole; derivatives; preparation
Prior art date: 1998-01-02

Application number

MA25410A

Other languages

English (en)

Inventor

Alig Leo

Edenhofer Albrecht

Weller Thomas

Hilpert Kurt

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-02

Filing date

1998-12-30

Publication date

2004-12-20

1998-12-30 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26590A1 publication Critical patent/MA26590A1/fr

Links

238000002360 preparation method Methods 0.000 title 1
150000007979 thiazole derivatives Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Virology (AREA)
Cardiology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

MA25410A 1998-01-02 1998-12-30 Derives de thiazole, leur procede de preparation et leur utilisation. MA26590A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98100007		1998-01-02

Publications (1)

Publication Number	Publication Date
MA26590A1 true MA26590A1 (fr)	2004-12-20

Family

ID=8231230

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25410A MA26590A1 (fr)	1998-01-02	1998-12-30	Derives de thiazole, leur procede de preparation et leur utilisation.

Country Status (28)

Country	Link
US (1)	US6001855A (fr)
JP (1)	JP3154982B2 (fr)
KR (1)	KR100312900B1 (fr)
CN (1)	CN1098849C (fr)
AR (1)	AR014211A1 (fr)
AT (1)	ATE217621T1 (fr)
AU (1)	AU718659B2 (fr)
BR (1)	BR9805750A (fr)
CA (1)	CA2257322C (fr)
CO (1)	CO4990935A1 (fr)
DE (1)	DE69805392T2 (fr)
DK (1)	DK0928793T3 (fr)
ES (1)	ES2176895T3 (fr)
HR (1)	HRP980644B1 (fr)
HU (1)	HUP9803041A3 (fr)
ID (1)	ID21878A (fr)
IL (1)	IL127784A (fr)
MA (1)	MA26590A1 (fr)
NO (1)	NO312134B1 (fr)
PE (1)	PE20000116A1 (fr)
PL (1)	PL330620A1 (fr)
PT (1)	PT928793E (fr)
RU (1)	RU2166503C2 (fr)
SG (1)	SG72911A1 (fr)
TR (1)	TR199802766A3 (fr)
UY (1)	UY25335A1 (fr)
YU (1)	YU60998A (fr)
ZA (1)	ZA9811923B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL142090A0 (en)	1998-10-22	2002-03-10	Hoffmann La Roche	Thiazole derivatives
JP4517454B2 (ja) *	2000-06-01	2010-08-04	宇部興産株式会社	４−（１−フルオロエチル）チアゾール−５−カルボン酸アミド誘導体及び農園芸用の有害生物防除剤
US6420566B2 (en) *	2000-06-09	2002-07-16	Aventis Pharma S.A.	Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof
US6451821B1 (en) *	2000-06-09	2002-09-17	Aventis Pharma S.A.	Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase
MX2018006729A (es) *	2015-12-04	2018-11-09	Janssen Biotech Inc	Tratamiento de la degeneracion de la retina mediante el uso de celulas progenitoras.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2138803B (en) *	1983-04-26	1986-06-18	Shionogi & Co	2-guanidino-4-hydroxymethylthiazole and derivatives thereof
GB8714920D0 (en) *	1987-06-25	1987-07-29	Shell Int Research	Thiazole derivatives
IL95548A0 (en) *	1989-09-15	1991-06-30	Fujisawa Pharmaceutical Co	Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
TW201303B (fr) *	1990-07-05	1993-03-01	Hoffmann La Roche
JPH0867676A (ja) *	1994-03-30	1996-03-12	Eisai Kagaku Kk	保護アミノチアゾリル酢酸誘導体
MX9801716A (es) *	1995-08-30	1998-05-31	Searle & Co	Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
EP0880511A4 (fr) *	1996-01-16	1999-06-16	Merck & Co Inc	Antagonistes du recepteur integrine
ATE244228T1 (de) *	1997-02-13	2003-07-15	Tokuyama Corp	Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate
US6359134B1 (en) *	1997-05-30	2002-03-19	Takeda Chemical Industries, Ltd.	Sulfonamide derivatives, their production and use

1998
- 1998-12-22 US US09/218,200 patent/US6001855A/en not_active Expired - Fee Related
- 1998-12-28 NO NO19986160A patent/NO312134B1/no unknown
- 1998-12-29 HR HR980644A patent/HRP980644B1/xx not_active IP Right Cessation
- 1998-12-29 AR ARP980106722A patent/AR014211A1/es not_active Application Discontinuation
- 1998-12-29 PE PE1998001292A patent/PE20000116A1/es not_active Application Discontinuation
- 1998-12-29 ZA ZA9811923A patent/ZA9811923B/xx unknown
- 1998-12-29 YU YU60998A patent/YU60998A/sh unknown
- 1998-12-29 IL IL12778498A patent/IL127784A/en not_active IP Right Cessation
- 1998-12-30 PL PL98330620A patent/PL330620A1/xx not_active Application Discontinuation
- 1998-12-30 ES ES98124819T patent/ES2176895T3/es not_active Expired - Lifetime
- 1998-12-30 AT AT98124819T patent/ATE217621T1/de not_active IP Right Cessation
- 1998-12-30 KR KR1019980061644A patent/KR100312900B1/ko not_active Expired - Fee Related
- 1998-12-30 CA CA002257322A patent/CA2257322C/fr not_active Expired - Fee Related
- 1998-12-30 DE DE69805392T patent/DE69805392T2/de not_active Expired - Fee Related
- 1998-12-30 CO CO98077474A patent/CO4990935A1/es unknown
- 1998-12-30 HU HU9803041A patent/HUP9803041A3/hu unknown
- 1998-12-30 PT PT98124819T patent/PT928793E/pt unknown
- 1998-12-30 DK DK98124819T patent/DK0928793T3/da active
- 1998-12-30 SG SG1998005979A patent/SG72911A1/en unknown
- 1998-12-30 AU AU96145/98A patent/AU718659B2/en not_active Ceased
- 1998-12-30 MA MA25410A patent/MA26590A1/fr unknown
- 1998-12-30 TR TR1998/02766A patent/TR199802766A3/tr unknown
- 1998-12-31 UY UY25335A patent/UY25335A1/es not_active IP Right Cessation
- 1998-12-31 BR BR9805750-2A patent/BR9805750A/pt not_active Application Discontinuation
- 1998-12-31 CN CN98125981A patent/CN1098849C/zh not_active Expired - Fee Related
1999
- 1999-01-04 JP JP00020699A patent/JP3154982B2/ja not_active Expired - Fee Related
- 1999-01-04 ID IDP990002A patent/ID21878A/id unknown
- 1999-01-05 RU RU99100205/04A patent/RU2166503C2/ru not_active IP Right Cessation

Also Published As

Publication number	Publication date
PT928793E (pt)	2002-10-31
PL330620A1 (en)	1999-07-05
CN1227225A (zh)	1999-09-01
JP2000053678A (ja)	2000-02-22
UY25335A1 (es)	2001-01-31
RU2166503C2 (ru)	2001-05-10
HUP9803041A2 (hu)	2000-04-28
DE69805392T2 (de)	2002-12-19
HU9803041D0 (en)	1999-02-01
IL127784A (en)	2001-09-13
PE20000116A1 (es)	2000-02-11
NO986160L (no)	1999-07-05
AU9614598A (en)	1999-07-22
DK0928793T3 (da)	2002-09-09
HRP980644B1 (en)	2003-08-31
IL127784A0 (en)	1999-10-28
AR014211A1 (es)	2001-02-07
US6001855A (en)	1999-12-14
KR100312900B1 (ko)	2002-01-17
AU718659B2 (en)	2000-04-20
KR19990066903A (ko)	1999-08-16
ATE217621T1 (de)	2002-06-15
CA2257322A1 (fr)	1999-07-02
NO986160D0 (no)	1998-12-28
JP3154982B2 (ja)	2001-04-09
TR199802766A2 (xx)	1999-07-21
TR199802766A3 (tr)	1999-07-21
SG72911A1 (en)	2000-05-23
CA2257322C (fr)	2003-11-04
NO312134B1 (no)	2002-03-25
YU60998A (sh)	2001-12-26
HRP980644A2 (en)	1999-10-31
ES2176895T3 (es)	2002-12-01
ID21878A (id)	1999-08-05
CO4990935A1 (es)	2000-12-26
DE69805392D1 (de)	2002-06-20
CN1098849C (zh)	2003-01-15
HUP9803041A3 (en)	2001-04-28
HK1021733A1 (en)	2000-06-30
ZA9811923B (en)	2000-06-29
BR9805750A (pt)	2001-04-24

Publication	Publication Date	Title
FR13C0008I2 (fr)	2013-08-16	Derives de phosphonocephem, leur procede de preparation et leur utilisation
FR2784107B1 (fr)	2005-12-09	Microfibrilles de cellulose a surface modifiee, leur procede de preparation, et leur utilisation
PT1056759E (pt)	2003-01-31	Derivados do 2-(purin-9-il)-tetrahidrofurano-3,4-diolc
IS4963A (is)	1999-01-29	Setnar 6,5-heteró-bísýklískar afleiður
DE69933287D1 (de)	2006-11-02	12,13-modifizierte epothilon-derivate
EE04721B1 (et)	2006-10-16	Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
NO20030800D0 (no)	2003-02-20	Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme
PT922050E (pt)	2003-12-31	Derivados de 3-descladinose-2,3-anidroeritromicina
MA26793A1 (fr)	2004-12-20	Derives de 4-phenyl-pyrimidine.
EE04089B1 (et)	2003-08-15	1,3,4-oksadiasolooni derivaadid
TR199700863A3 (tr)	1999-10-21	Paklitaksel hazirlama prosesi.
ES1040916Y (es)	1999-11-01	Microterminal perfeccionado.
TR199700219A3 (tr)	1997-10-21	1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
FR2797443B1 (fr)	2003-10-31	Procede de prepartion de quinoleine-5,8-diones
ES1027007Y (es)	1995-01-16	Dispositivo facofragmentador de nucleo, desechable.
ES1039265Y (es)	1999-05-16	Rocodromo perfeccionado.
ES1040277Y (es)	1999-07-01	Agrupador de perchas perfeccionado.
ES1028142Y (es)	1995-05-01	Pantalla antidesprendimiento de rocas, perfeccionada.
ES1039868Y (es)	1999-06-16	Eslabon giratorio perfeccionado.
ES1039554Y (es)	1999-05-16	Prenda interior perfeccionada.
ES1033065Y (es)	1996-12-16	Conjunto canula-tapa, perfeccionado.
ES1041554Y (es)	1999-12-16	Pantalon perfeccionado.
ES1039261Y (es)	1999-05-16	Estuche perfeccionado.
ES1031448Y (es)	1996-06-01	Maquina cortadora-pesadora de alimentos, perfeccionada.
ES1043757Y (es)	2000-06-16	Camison perfeccionado.